1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview
1.1 Product Overview and Scope of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type
1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 CH-1R Strain
1.2.3 PC Strain
1.2.4 Others
1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application
1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application: (2023-2029)
1.3.2 Gilts
1.3.3 Sows
1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts
1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2018-2029
1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2018-2029
1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competition by Manufacturers
2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
2.7 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation and Trends
2.7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue
2.7.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Retrospective Market Scenario by Region
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2029
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2023
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2024-2029
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2029
3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2023
3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2024-2029
3.4 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.4.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.5.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.7.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.7.3 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2029)
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2023)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2024-2029)
4.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2018-2029)
4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2029)
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2023)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2024-2029)
4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2029)
5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2023)
5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2024-2029)
5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2018-2029)
5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2029)
5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2023)
5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2024-2029)
5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 HIPRA
6.2.1 HIPRA Corporation Information
6.2.2 HIPRA Description and Business Overview
6.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.2.5 HIPRA Recent Developments/Updates
6.3 Sinopharm Animal Health Co., Ltd
6.3.1 Sinopharm Animal Health Co., Ltd Corporation Information
6.3.2 Sinopharm Animal Health Co., Ltd Description and Business Overview
6.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.3.5 Sinopharm Animal Health Co., Ltd Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 CAVAC
6.5.1 CAVAC Corporation Information
6.5.2 CAVAC Description and Business Overview
6.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.5.5 CAVAC Recent Developments/Updates
6.6 Bioveta
6.6.1 Bioveta Corporation Information
6.6.2 Bioveta Description and Business Overview
6.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.6.5 Bioveta Recent Developments/Updates
6.7 Jinyu Bio-Technology
6.6.1 Jinyu Bio-Technology Corporation Information
6.6.2 Jinyu Bio-Technology Description and Business Overview
6.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.7.5 Jinyu Bio-Technology Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Corporation Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Chain Analysis
7.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
7.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Marketing
7.4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels
7.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
7.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
8 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
8.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
8.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 PIG豚繁殖呼吸器症候群（PRRS）ワクチンは、豚に影響を及ぼす重要なウイルス性疾患であるPRRSを予防するための生物学的製剤です。この疾患は、豚の繁殖と呼吸器系に重大な影響を及ぼし、その結果、農業経済に深刻な打撃を与える可能性があります。以下に、PRRSワクチンの定義、特徴、種類、用途、関連技術について詳しく説明いたします。 PRRSは、豚に特有の病気で、PRRSウイルスが原因です。このウイルスには、アフリカ豚熱ウイルスと同じく、単鎖RNAウイルスという特徴があります。PRRSウイルスは主に、繁殖豚や成豚に感染し、流産、早産、不妊、及び新生子豚の死亡などの生殖問題を引き起こす一方、若豚には呼吸器疾患をもたらすことがあります。そのため、PRRSワクチンは豚の健康を維持する上で非常に重要な役割を果たします。 PRRSワクチンの主な特徴には、免疫応答を促進するための成分が含まれていることが挙げられます。これにより、豚の免疫系はPRRSウイルスに対して認識し、効果的に防御する能力を高めます。ワクチンは、通常不活化ワクチンや生ワクチンとして製造されることが多いですが、それぞれに異なる特性があります。生ワクチンは、ウイルスが弱毒化されたもので、より強い免疫応答を誘導することが期待されますが、一方で感染のリスクも伴う場合があります。不活化ワクチンは、ウイルスが死滅しているため安全性が高いものの、免疫応答がやや弱いとされることがあります。 PRRSワクチンは、豚の飼育環境や生産システムによって異なるさまざまな用途に使用されます。農場経営者は、豚の免疫状況を把握し、PRRS感染のリスクを低減するためにワクチン接種を計画します。また、新たに導入した豚は、既存の群れに感染を持ち込む可能性を減らすために、ワクチン接種が必須となります。これにより、畜産業の生産性が向上し、経済的な損失を最小限に抑えることが可能になります。 PRRSワクチンに関連付けられる技術としては、遺伝子工学や分子生物学の手法が挙げられます。これにより、ウイルスの特定の遺伝子をターゲットとして、より効果的なワクチンの設計が可能になります。さらに、ワクチンの開発においては、ワクチンの効能を測るための診断技術も重要です。例えば、抗体価の測定やウイルス分離などの手法によって、ワクチン接種後の免疫応答を評価することができます。 PRRSワクチンの導入は、豚の個体の健康を保つだけでなく、豚肉の供給の安定性をも向上させることに寄与します。消費者にとっても、病気の蔓延を防ぐことによって、安全な食肉を提供するための基盤となります。ただし、ワクチン接種にあたっては一定の注意が求められます。適切な接種のタイミングや、使用するワクチンの種類、そして接種後の監視体制をしっかり整えることが重要です。 また、PRRSワクチンは他の伝染病ワクチンと同様に、単独で効果を発揮するのではなく、全体的な防疫対策の一環として実施されるべきです。豚舎の衛生管理や感染対策、栄養管理などの総合的な観点から、効果的な感染症対策を講じることが重要です。 現在の研究では、PRRSワクチンの改良が続けられており、より高い効果や安全性を持つ新しいワクチンの開発が期待されています。特に、ウイルスの変異株に対する効果を持つワクチンの開発が進められており、これにより感染症の広がりを防ぐ手段を提供することが目指されています。また、ワクチンの投与スケジュールや方法についても、研究が進み、最適化が進められています。 このように、PIG豚繁殖呼吸器症候群（PRRS）ワクチンは、豚の健康管理において極めて重要な要素であり、それに伴う技術や知識の向上が、畜産業の持続可能な発展に寄与することが期待されます。今後の研究と技術の進展が、PRRSワクチンの効果をさらに高め、豚の健康を守り、全体的な生産性を向上させる道を切り開くことでしょう。 |
